Gillory LA, Megison ML, Stewart JE, Mroczek-Musulman E, Nabers HC, Waters AM,Kelly V, Coleman JM, Markert JM, Gillespie GY, Friedman GK, Beierle EA.Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma. PLoS One. 2013 Oct 10;8(10):e77753. doi:10.1371/journal.pone.0077753. eCollection 2013. |
PMID: 24130898 |
Lacher M, Yannam GR, Muensterer OJ, Aprahamian CJ, Haricharan RN, Perger L, Bartle D, Talathi SS, Beierle EA, Anderson SA, Chen MK, Harmon CM. Laparoscopic cholecystectomy for biliary dyskinesia in children: frequency increasing. J Pediatr Surg. 2013 Aug;48(8):1716-21. doi: 10.1016/j.jpedsurg.2012.08.036. |
PMID: 23932611 |
Levy AS, Pyke-Grimm KA, Lee DA, Palla SL, Naranjo A, Saulnier Sholler G,Gratias E, Maloney K, Parshankar F, Lee-Scott M, Beierle EA, Gow K, Kim GE,Hunger S, Smith FO, Horton TM. Mentoring in pediatric oncology: a report from the Children's Oncology Group Young Investigator Committee. J Pediatr Hematol Oncol. 2013 Aug;35(6):45661.doi:10.1097/MPH.0b013e31829eec33. |
PMID: 23892351 |
Stewart JE, Ma X, Megison M, Nabers H, Cance WG, Kurenova EV, Beierle EA.Inhibition of FAK and VEGFR-3 binding decreases tumorigenicity in neuroblastoma. Mol Carcinog. 2013 Jul 19. doi: 10.1002/mc.22070. [Epub ahead of print] PubMed |
PMID: 23868727 |
Waters AM, Beierle EA. The interaction between FAK, MYCN, p53 and Mdm2 in neuroblastoma. Anticancer Agents Med Chem. 2014 Jan;14(1):46-51. Review. |
PMID: 24041229 |
|